Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study

Stefano Margaritora, Maria Lucia Calcagni, Giovanna Mantini, Valeria Valentini, Bruno Meduri, Luigia Nardone, Fiorenza De Rose, Alfredo Cesario, Pierluigi Granone, Marinella Balducci, F Micciché, Ar Larici, F Maggi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)

Abstract

Low-dose radiotherapy (LDR) (<50 cGy) induces enhanced cell killing in vitro via the hyper-radiation sensitivity phenomenon. Aim of this study was to evaluate the safety and efficacy of a palliative regimen combining pemetrexed and LDR (as a chemopotentiator) on patients affected by recurrent non-small-cell lung cancer (NSCLC).
Lingua originaleEnglish
pagine (da-a)161-166
Numero di pagine6
RivistaRadiotherapy and Oncology
Volume105
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • nsclc

Fingerprint

Entra nei temi di ricerca di 'Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study'. Insieme formano una fingerprint unica.

Cita questo